https://jneuroinflammation.biomedcentra ... 014-0165-8
a medication that already exists for people with this deficiency to help reduce their emphysema and liver disease could be useful in fighting AD.
I know from my lung issues that I carry one less-than-ideal version of the gene that causes alpha-1 antitrypsin deficiency. My combo is shared by 8% of the population and isn't considered pathogenic, though it does mean I make on average only 80% of normal of this substance that dampens inflammation.
Random side note, I also know from other research that the quantity of A-1AT a person produces during an immune system activation is also linked to their weight, with being underweight a bad thing.
Anyone who has done Promethease can look up their genes for this condition. My "less-than-ideal but still normal" gene situation doesn't qualify for the med...